-
Posted by
Two Blokes Thu at 2:30 PM -
Filed in
Stock
-
2 views
Akebia Therapeutics (AKBA) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.03 per share. This compares to loss of $0.09 per share a year ago.
